nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Sinus headache—Telbivudine—hepatitis B	0.044	0.0462	CcSEcCtD
Atomoxetine—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0213	0.0223	CcSEcCtD
Atomoxetine—Laryngeal pain—Telbivudine—hepatitis B	0.0211	0.0221	CcSEcCtD
Atomoxetine—Urinary hesitation—Lamivudine—hepatitis B	0.0197	0.0207	CcSEcCtD
Atomoxetine—Rhinorrhoea—Telbivudine—hepatitis B	0.0177	0.0186	CcSEcCtD
Atomoxetine—Suicide attempt—Lamivudine—hepatitis B	0.0143	0.015	CcSEcCtD
Atomoxetine—Hepatic failure—Entecavir—hepatitis B	0.0141	0.0148	CcSEcCtD
Atomoxetine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0138	0.0144	CcSEcCtD
Atomoxetine—Completed suicide—Lamivudine—hepatitis B	0.0138	0.0144	CcSEcCtD
Atomoxetine—Abdominal pain upper—Entecavir—hepatitis B	0.0116	0.0122	CcSEcCtD
Atomoxetine—Throat sore—Lamivudine—hepatitis B	0.0112	0.0118	CcSEcCtD
Atomoxetine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0111	0.0117	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Entecavir—hepatitis B	0.0102	0.0107	CcSEcCtD
Atomoxetine—Rhinorrhoea—Lamivudine—hepatitis B	0.00999	0.0105	CcSEcCtD
Atomoxetine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00968	0.0102	CcSEcCtD
Atomoxetine—Abdominal pain upper—Telbivudine—hepatitis B	0.00952	0.00999	CcSEcCtD
Atomoxetine—Nasopharyngitis—Telbivudine—hepatitis B	0.00932	0.00978	CcSEcCtD
Atomoxetine—Influenza—Telbivudine—hepatitis B	0.00901	0.00945	CcSEcCtD
Atomoxetine—Bone disorder—Lamivudine—hepatitis B	0.00896	0.0094	CcSEcCtD
Atomoxetine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00895	0.00939	CcSEcCtD
Atomoxetine—Pseudoephedrine—IL2—hepatitis B	0.00893	0.413	CrCbGaD
Atomoxetine—Oropharyngeal pain—Lamivudine—hepatitis B	0.0089	0.00933	CcSEcCtD
Atomoxetine—Drug interaction—Lamivudine—hepatitis B	0.00872	0.00915	CcSEcCtD
Atomoxetine—Abdominal discomfort—Telbivudine—hepatitis B	0.00863	0.00906	CcSEcCtD
Atomoxetine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00846	0.00887	CcSEcCtD
Atomoxetine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00839	0.00881	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00837	0.00878	CcSEcCtD
Atomoxetine—Mental disorder—Entecavir—hepatitis B	0.00769	0.00807	CcSEcCtD
Atomoxetine—Malnutrition—Entecavir—hepatitis B	0.00764	0.00801	CcSEcCtD
Atomoxetine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00745	0.00782	CcSEcCtD
Atomoxetine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00734	0.00771	CcSEcCtD
Atomoxetine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00721	0.00756	CcSEcCtD
Atomoxetine—Hypoaesthesia—Telbivudine—hepatitis B	0.00717	0.00753	CcSEcCtD
Atomoxetine—Sleep disorder—Lamivudine—hepatitis B	0.00678	0.00712	CcSEcCtD
Atomoxetine—Cough—Adefovir Dipivoxil—hepatitis B	0.0065	0.00682	CcSEcCtD
Atomoxetine—Mediastinal disorder—Telbivudine—hepatitis B	0.0065	0.00682	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00646	0.00678	CcSEcCtD
Atomoxetine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00635	0.00666	CcSEcCtD
Atomoxetine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00635	0.00666	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0063	0.00661	CcSEcCtD
Atomoxetine—Malnutrition—Telbivudine—hepatitis B	0.00628	0.00658	CcSEcCtD
Atomoxetine—Infection—Entecavir—hepatitis B	0.00619	0.0065	CcSEcCtD
Atomoxetine—Thirst—Lamivudine—hepatitis B	0.00617	0.00647	CcSEcCtD
Atomoxetine—Dysgeusia—Telbivudine—hepatitis B	0.00615	0.00645	CcSEcCtD
Atomoxetine—Nervous system disorder—Entecavir—hepatitis B	0.00611	0.00641	CcSEcCtD
Atomoxetine—Back pain—Telbivudine—hepatitis B	0.00607	0.00637	CcSEcCtD
Atomoxetine—Skin disorder—Entecavir—hepatitis B	0.00606	0.00635	CcSEcCtD
Atomoxetine—Muscle spasms—Telbivudine—hepatitis B	0.00603	0.00633	CcSEcCtD
Atomoxetine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00597	0.00626	CcSEcCtD
Atomoxetine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00591	0.0062	CcSEcCtD
Atomoxetine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0058	0.00608	CcSEcCtD
Atomoxetine—Affect lability—Lamivudine—hepatitis B	0.00578	0.00606	CcSEcCtD
Atomoxetine—Insomnia—Entecavir—hepatitis B	0.00564	0.00592	CcSEcCtD
Atomoxetine—Mood swings—Lamivudine—hepatitis B	0.00556	0.00584	CcSEcCtD
Atomoxetine—Somnolence—Entecavir—hepatitis B	0.00554	0.00582	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00554	0.00581	CcSEcCtD
Atomoxetine—Dyspepsia—Entecavir—hepatitis B	0.00549	0.00576	CcSEcCtD
Atomoxetine—Cough—Telbivudine—hepatitis B	0.00548	0.00575	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00538	0.00565	CcSEcCtD
Atomoxetine—Fatigue—Entecavir—hepatitis B	0.00538	0.00564	CcSEcCtD
Atomoxetine—Abdominal pain upper—Lamivudine—hepatitis B	0.00536	0.00563	CcSEcCtD
Atomoxetine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00535	0.00562	CcSEcCtD
Atomoxetine—Chest pain—Telbivudine—hepatitis B	0.00534	0.00561	CcSEcCtD
Atomoxetine—Myalgia—Telbivudine—hepatitis B	0.00534	0.00561	CcSEcCtD
Atomoxetine—Arthralgia—Telbivudine—hepatitis B	0.00534	0.00561	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00531	0.00557	CcSEcCtD
Atomoxetine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00529	0.00555	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00525	0.00551	CcSEcCtD
Atomoxetine—Nasopharyngitis—Lamivudine—hepatitis B	0.00525	0.00551	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Entecavir—hepatitis B	0.0051	0.00535	CcSEcCtD
Atomoxetine—Influenza—Lamivudine—hepatitis B	0.00508	0.00533	CcSEcCtD
Atomoxetine—Nervous system disorder—Telbivudine—hepatitis B	0.00502	0.00527	CcSEcCtD
Atomoxetine—Skin disorder—Telbivudine—hepatitis B	0.00497	0.00522	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00497	0.00522	CcSEcCtD
Atomoxetine—Sweating increased—Lamivudine—hepatitis B	0.00494	0.00519	CcSEcCtD
Atomoxetine—Abdominal pain—Entecavir—hepatitis B	0.00493	0.00517	CcSEcCtD
Atomoxetine—Body temperature increased—Entecavir—hepatitis B	0.00493	0.00517	CcSEcCtD
Atomoxetine—Abdominal discomfort—Lamivudine—hepatitis B	0.00487	0.00511	CcSEcCtD
Atomoxetine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00481	0.00505	CcSEcCtD
Atomoxetine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00481	0.00505	CcSEcCtD
Atomoxetine—Dysuria—Lamivudine—hepatitis B	0.00475	0.00498	CcSEcCtD
Atomoxetine—Pollakiuria—Lamivudine—hepatitis B	0.00469	0.00492	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00467	0.0049	CcSEcCtD
Atomoxetine—Insomnia—Telbivudine—hepatitis B	0.00463	0.00486	CcSEcCtD
Atomoxetine—Paraesthesia—Telbivudine—hepatitis B	0.0046	0.00483	CcSEcCtD
Atomoxetine—Depression—Lamivudine—hepatitis B	0.00451	0.00473	CcSEcCtD
Atomoxetine—Dyspepsia—Telbivudine—hepatitis B	0.00451	0.00473	CcSEcCtD
Atomoxetine—Asthenia—Entecavir—hepatitis B	0.00447	0.00469	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00442	0.00464	CcSEcCtD
Atomoxetine—Fatigue—Telbivudine—hepatitis B	0.00442	0.00463	CcSEcCtD
Atomoxetine—Pain—Telbivudine—hepatitis B	0.00438	0.0046	CcSEcCtD
Atomoxetine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00436	0.00458	CcSEcCtD
Atomoxetine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0043	0.00452	CcSEcCtD
Atomoxetine—Diarrhoea—Entecavir—hepatitis B	0.00427	0.00448	CcSEcCtD
Atomoxetine—Sinusitis—Lamivudine—hepatitis B	0.00425	0.00445	CcSEcCtD
Atomoxetine—Feeling abnormal—Telbivudine—hepatitis B	0.00422	0.00443	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00419	0.00439	CcSEcCtD
Atomoxetine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00416	0.00437	CcSEcCtD
Atomoxetine—Dizziness—Entecavir—hepatitis B	0.00412	0.00433	CcSEcCtD
Atomoxetine—Abdominal pain—Telbivudine—hepatitis B	0.00405	0.00425	CcSEcCtD
Atomoxetine—Body temperature increased—Telbivudine—hepatitis B	0.00405	0.00425	CcSEcCtD
Atomoxetine—Hypoaesthesia—Lamivudine—hepatitis B	0.00404	0.00424	CcSEcCtD
Atomoxetine—Vomiting—Entecavir—hepatitis B	0.00396	0.00416	CcSEcCtD
Atomoxetine—Rash—Entecavir—hepatitis B	0.00393	0.00412	CcSEcCtD
Atomoxetine—Dermatitis—Entecavir—hepatitis B	0.00393	0.00412	CcSEcCtD
Atomoxetine—Headache—Entecavir—hepatitis B	0.00391	0.0041	CcSEcCtD
Atomoxetine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00387	0.00406	CcSEcCtD
Atomoxetine—Rash—Adefovir Dipivoxil—hepatitis B	0.00384	0.00402	CcSEcCtD
Atomoxetine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00383	0.00402	CcSEcCtD
Atomoxetine—Headache—Adefovir Dipivoxil—hepatitis B	0.00381	0.004	CcSEcCtD
Atomoxetine—Nausea—Entecavir—hepatitis B	0.0037	0.00389	CcSEcCtD
Atomoxetine—Asthenia—Telbivudine—hepatitis B	0.00367	0.00386	CcSEcCtD
Atomoxetine—Mediastinal disorder—Lamivudine—hepatitis B	0.00366	0.00384	CcSEcCtD
Atomoxetine—Chills—Lamivudine—hepatitis B	0.00365	0.00382	CcSEcCtD
Atomoxetine—Pruritus—Telbivudine—hepatitis B	0.00362	0.0038	CcSEcCtD
Atomoxetine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00361	0.00379	CcSEcCtD
Atomoxetine—Malnutrition—Lamivudine—hepatitis B	0.00354	0.00371	CcSEcCtD
Atomoxetine—Diarrhoea—Telbivudine—hepatitis B	0.0035	0.00368	CcSEcCtD
Atomoxetine—Flatulence—Lamivudine—hepatitis B	0.00348	0.00366	CcSEcCtD
Atomoxetine—Tension—Lamivudine—hepatitis B	0.00347	0.00364	CcSEcCtD
Atomoxetine—Dysgeusia—Lamivudine—hepatitis B	0.00346	0.00363	CcSEcCtD
Atomoxetine—Nervousness—Lamivudine—hepatitis B	0.00343	0.0036	CcSEcCtD
Atomoxetine—Back pain—Lamivudine—hepatitis B	0.00342	0.00359	CcSEcCtD
Atomoxetine—Muscle spasms—Lamivudine—hepatitis B	0.0034	0.00357	CcSEcCtD
Atomoxetine—Dizziness—Telbivudine—hepatitis B	0.00339	0.00355	CcSEcCtD
Atomoxetine—Tremor—Lamivudine—hepatitis B	0.00331	0.00348	CcSEcCtD
Atomoxetine—Vomiting—Telbivudine—hepatitis B	0.00326	0.00342	CcSEcCtD
Atomoxetine—Rash—Telbivudine—hepatitis B	0.00323	0.00339	CcSEcCtD
Atomoxetine—Dermatitis—Telbivudine—hepatitis B	0.00323	0.00338	CcSEcCtD
Atomoxetine—Headache—Telbivudine—hepatitis B	0.00321	0.00337	CcSEcCtD
Atomoxetine—Vertigo—Lamivudine—hepatitis B	0.00318	0.00333	CcSEcCtD
Atomoxetine—Syncope—Lamivudine—hepatitis B	0.00317	0.00333	CcSEcCtD
Atomoxetine—Loss of consciousness—Lamivudine—hepatitis B	0.00311	0.00326	CcSEcCtD
Atomoxetine—Cough—Lamivudine—hepatitis B	0.00309	0.00324	CcSEcCtD
Atomoxetine—Convulsion—Lamivudine—hepatitis B	0.00306	0.00321	CcSEcCtD
Atomoxetine—Nausea—Telbivudine—hepatitis B	0.00304	0.00319	CcSEcCtD
Atomoxetine—Pseudoephedrine—TNF—hepatitis B	0.00302	0.139	CrCbGaD
Atomoxetine—Myalgia—Lamivudine—hepatitis B	0.00301	0.00316	CcSEcCtD
Atomoxetine—Chest pain—Lamivudine—hepatitis B	0.00301	0.00316	CcSEcCtD
Atomoxetine—Arthralgia—Lamivudine—hepatitis B	0.00301	0.00316	CcSEcCtD
Atomoxetine—Anxiety—Lamivudine—hepatitis B	0.003	0.00315	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00299	0.00314	CcSEcCtD
Atomoxetine—Dry mouth—Lamivudine—hepatitis B	0.00294	0.00309	CcSEcCtD
Atomoxetine—Infection—Lamivudine—hepatitis B	0.00287	0.00301	CcSEcCtD
Atomoxetine—Shock—Lamivudine—hepatitis B	0.00284	0.00298	CcSEcCtD
Atomoxetine—Nervous system disorder—Lamivudine—hepatitis B	0.00283	0.00297	CcSEcCtD
Atomoxetine—Skin disorder—Lamivudine—hepatitis B	0.0028	0.00294	CcSEcCtD
Atomoxetine—Hyperhidrosis—Lamivudine—hepatitis B	0.00279	0.00293	CcSEcCtD
Atomoxetine—Anorexia—Lamivudine—hepatitis B	0.00275	0.00289	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00263	0.00276	CcSEcCtD
Atomoxetine—Insomnia—Lamivudine—hepatitis B	0.00261	0.00274	CcSEcCtD
Atomoxetine—Paraesthesia—Lamivudine—hepatitis B	0.00259	0.00272	CcSEcCtD
Atomoxetine—Somnolence—Lamivudine—hepatitis B	0.00257	0.00269	CcSEcCtD
Atomoxetine—Dyspepsia—Lamivudine—hepatitis B	0.00254	0.00267	CcSEcCtD
Atomoxetine—Decreased appetite—Lamivudine—hepatitis B	0.00251	0.00263	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00249	0.00261	CcSEcCtD
Atomoxetine—Fatigue—Lamivudine—hepatitis B	0.00249	0.00261	CcSEcCtD
Atomoxetine—Pain—Lamivudine—hepatitis B	0.00247	0.00259	CcSEcCtD
Atomoxetine—Constipation—Lamivudine—hepatitis B	0.00247	0.00259	CcSEcCtD
Atomoxetine—Feeling abnormal—Lamivudine—hepatitis B	0.00238	0.0025	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00236	0.00248	CcSEcCtD
Atomoxetine—Urticaria—Lamivudine—hepatitis B	0.00229	0.00241	CcSEcCtD
Atomoxetine—Body temperature increased—Lamivudine—hepatitis B	0.00228	0.00239	CcSEcCtD
Atomoxetine—Abdominal pain—Lamivudine—hepatitis B	0.00228	0.00239	CcSEcCtD
Atomoxetine—Asthenia—Lamivudine—hepatitis B	0.00207	0.00217	CcSEcCtD
Atomoxetine—Pruritus—Lamivudine—hepatitis B	0.00204	0.00214	CcSEcCtD
Atomoxetine—Diarrhoea—Lamivudine—hepatitis B	0.00197	0.00207	CcSEcCtD
Atomoxetine—Dizziness—Lamivudine—hepatitis B	0.00191	0.002	CcSEcCtD
Atomoxetine—Vomiting—Lamivudine—hepatitis B	0.00184	0.00193	CcSEcCtD
Atomoxetine—Rash—Lamivudine—hepatitis B	0.00182	0.00191	CcSEcCtD
Atomoxetine—Dermatitis—Lamivudine—hepatitis B	0.00182	0.00191	CcSEcCtD
Atomoxetine—Headache—Lamivudine—hepatitis B	0.00181	0.0019	CcSEcCtD
Atomoxetine—Fenoprofen—ALB—hepatitis B	0.00175	0.081	CrCbGaD
Atomoxetine—Desipramine—CYP2A6—hepatitis B	0.00174	0.0805	CrCbGaD
Atomoxetine—Nausea—Lamivudine—hepatitis B	0.00171	0.0018	CcSEcCtD
Atomoxetine—Phenprocoumon—ALB—hepatitis B	0.00151	0.0699	CrCbGaD
Atomoxetine—Fluoxetine—ALB—hepatitis B	0.00147	0.068	CrCbGaD
Atomoxetine—Warfarin—ALB—hepatitis B	0.00134	0.062	CrCbGaD
Atomoxetine—Ketoprofen—ALB—hepatitis B	0.00103	0.0478	CrCbGaD
Atomoxetine—Nortriptyline—ALB—hepatitis B	0.000825	0.0381	CrCbGaD
Atomoxetine—SLC6A3—Monoamine Transport—TNF—hepatitis B	0.000151	0.00598	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—CCR5—hepatitis B	0.000148	0.00585	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000147	0.00581	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—SAG—hepatitis B	0.000146	0.00579	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—RIT2—hepatitis B	0.000146	0.00579	CbGpPWpGaD
Atomoxetine—SLC6A3—NRF2 pathway—GGT1—hepatitis B	0.000143	0.00565	CbGpPWpGaD
Atomoxetine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000142	0.0056	CbGpPWpGaD
Atomoxetine—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000139	0.00549	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000135	0.00534	CbGpPWpGaD
Atomoxetine—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000128	0.00505	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—F2—hepatitis B	0.000127	0.00502	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000124	0.00491	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Other—CCR5—hepatitis B	0.000123	0.00487	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—CXCL10—hepatitis B	0.000115	0.00456	CbGpPWpGaD
Atomoxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000114	0.00452	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—CXCL10—hepatitis B	0.000113	0.00447	CbGpPWpGaD
Atomoxetine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000113	0.00446	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—CXCL10—hepatitis B	0.000108	0.00426	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—FAS—hepatitis B	0.000107	0.00425	CbGpPWpGaD
Atomoxetine—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000107	0.00424	CbGpPWpGaD
Atomoxetine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	9.85e-05	0.0039	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CXCL10—hepatitis B	9.78e-05	0.00387	CbGpPWpGaD
Atomoxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	9.25e-05	0.00366	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	9.23e-05	0.00365	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—NOS2—hepatitis B	9.19e-05	0.00364	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	9.16e-05	0.00363	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	8.97e-05	0.00355	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—CCR5—hepatitis B	8.93e-05	0.00354	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL10—hepatitis B	8.84e-05	0.0035	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—CCR5—hepatitis B	8.75e-05	0.00346	CbGpPWpGaD
Atomoxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	8.35e-05	0.00331	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—CCR5—hepatitis B	8.35e-05	0.00331	CbGpPWpGaD
Atomoxetine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	8.35e-05	0.0033	CbGpPWpGaD
Atomoxetine—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	8.29e-05	0.00328	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	8.17e-05	0.00324	CbGpPWpGaD
Atomoxetine—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	8.12e-05	0.00321	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—GGT2—hepatitis B	8.11e-05	0.00321	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CCR5—hepatitis B	7.58e-05	0.003	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	7.52e-05	0.00298	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	7.4e-05	0.00293	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	7.18e-05	0.00284	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—F2—hepatitis B	7.16e-05	0.00284	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	7.16e-05	0.00283	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	7.1e-05	0.00281	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CXCL10—hepatitis B	7.03e-05	0.00278	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CXCL10—hepatitis B	6.98e-05	0.00276	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	6.96e-05	0.00275	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CXCL10—hepatitis B	6.83e-05	0.0027	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—F2—hepatitis B	6.83e-05	0.0027	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	6.8e-05	0.00269	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—F2—hepatitis B	6.51e-05	0.00258	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—GGT1—hepatitis B	6.38e-05	0.00253	CbGpPWpGaD
Atomoxetine—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	6.31e-05	0.0025	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	6.15e-05	0.00244	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.14e-05	0.00243	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	6.11e-05	0.00242	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.09e-05	0.00241	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	5.97e-05	0.00236	CbGpPWpGaD
Atomoxetine—HTR2A—G alpha (q) signalling events—F2—hepatitis B	5.93e-05	0.00235	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	5.9e-05	0.00234	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	5.89e-05	0.00233	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—GGT1—hepatitis B	5.87e-05	0.00232	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CXCL10—hepatitis B	5.78e-05	0.00229	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	5.59e-05	0.00221	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CCR5—hepatitis B	5.45e-05	0.00216	CbGpPWpGaD
Atomoxetine—SLC6A2—NRF2 pathway—TGFB1—hepatitis B	5.42e-05	0.00215	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CCR5—hepatitis B	5.41e-05	0.00214	CbGpPWpGaD
Atomoxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—hepatitis B	5.41e-05	0.00214	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.4e-05	0.00214	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SAG—hepatitis B	5.4e-05	0.00214	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RIT2—hepatitis B	5.4e-05	0.00214	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SAG—hepatitis B	5.36e-05	0.00212	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RIT2—hepatitis B	5.36e-05	0.00212	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	5.34e-05	0.00211	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	5.3e-05	0.0021	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CCR5—hepatitis B	5.3e-05	0.0021	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	5.27e-05	0.00209	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SAG—hepatitis B	5.25e-05	0.00208	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RIT2—hepatitis B	5.25e-05	0.00208	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CXCL10—hepatitis B	5.18e-05	0.00205	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	4.92e-05	0.00195	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—IL2—hepatitis B	4.83e-05	0.00191	CbGpPWpGaD
Atomoxetine—SLC6A3—NRF2 pathway—TGFB1—hepatitis B	4.81e-05	0.0019	CbGpPWpGaD
Atomoxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—hepatitis B	4.79e-05	0.0019	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—F2—hepatitis B	4.68e-05	0.00185	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—F2—hepatitis B	4.64e-05	0.00184	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	4.58e-05	0.00181	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—F2—hepatitis B	4.54e-05	0.0018	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	4.52e-05	0.00179	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	4.51e-05	0.00178	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL10—hepatitis B	4.49e-05	0.00178	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCR5—hepatitis B	4.48e-05	0.00177	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	4.46e-05	0.00176	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL2—hepatitis B	4.38e-05	0.00173	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—hepatitis B	4.32e-05	0.00171	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	4.02e-05	0.00159	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCR5—hepatitis B	4.01e-05	0.00159	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SAG—hepatitis B	3.98e-05	0.00157	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RIT2—hepatitis B	3.98e-05	0.00157	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL10—hepatitis B	3.97e-05	0.00157	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL10—hepatitis B	3.94e-05	0.00156	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	3.93e-05	0.00155	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL10—hepatitis B	3.86e-05	0.00153	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—F2—hepatitis B	3.84e-05	0.00152	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.84e-05	0.00152	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	3.68e-05	0.00146	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL10—hepatitis B	3.61e-05	0.00143	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL10—hepatitis B	3.58e-05	0.00142	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL10—hepatitis B	3.51e-05	0.00139	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCR5—hepatitis B	3.49e-05	0.00138	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RIT2—hepatitis B	3.45e-05	0.00137	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SAG—hepatitis B	3.45e-05	0.00137	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—F2—hepatitis B	3.44e-05	0.00136	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—hepatitis B	3.36e-05	0.00133	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCR5—hepatitis B	3.08e-05	0.00122	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCR5—hepatitis B	3.06e-05	0.00121	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCR5—hepatitis B	2.99e-05	0.00118	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—F2—hepatitis B	2.99e-05	0.00118	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL10—hepatitis B	2.93e-05	0.00116	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCR5—hepatitis B	2.8e-05	0.00111	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCR5—hepatitis B	2.78e-05	0.0011	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	2.75e-05	0.00109	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR5—hepatitis B	2.72e-05	0.00108	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—hepatitis B	2.71e-05	0.00107	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL10—hepatitis B	2.66e-05	0.00105	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—F2—hepatitis B	2.64e-05	0.00105	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—F2—hepatitis B	2.62e-05	0.00104	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL2—hepatitis B	2.59e-05	0.00102	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—hepatitis B	2.58e-05	0.00102	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—F2—hepatitis B	2.57e-05	0.00102	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL10—hepatitis B	2.54e-05	0.00101	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CTNNB1—hepatitis B	2.5e-05	0.000989	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.45e-05	0.00097	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CDKN1A—hepatitis B	2.44e-05	0.000966	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—PTEN—hepatitis B	2.44e-05	0.000964	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	2.43e-05	0.000963	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NFKB1—hepatitis B	2.42e-05	0.000959	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.42e-05	0.000957	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AKR1B1—hepatitis B	2.41e-05	0.000953	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—F2—hepatitis B	2.4e-05	0.00095	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—F2—hepatitis B	2.38e-05	0.000943	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—F2—hepatitis B	2.33e-05	0.000923	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT2—hepatitis B	2.31e-05	0.000913	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL10—hepatitis B	2.31e-05	0.000913	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR5—hepatitis B	2.27e-05	0.000898	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AKR1B1—hepatitis B	2.21e-05	0.000876	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL10—hepatitis B	2.13e-05	0.000843	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT2—hepatitis B	2.12e-05	0.00084	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL10—hepatitis B	2.11e-05	0.000837	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.1e-05	0.000831	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL10—hepatitis B	2.07e-05	0.00082	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR5—hepatitis B	2.06e-05	0.000815	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—hepatitis B	2.02e-05	0.000799	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR5—hepatitis B	1.97e-05	0.00078	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—F2—hepatitis B	1.95e-05	0.00077	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR5—hepatitis B	1.79e-05	0.000708	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2—hepatitis B	1.78e-05	0.000705	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—F2—hepatitis B	1.77e-05	0.0007	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2—hepatitis B	1.77e-05	0.000699	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2—hepatitis B	1.73e-05	0.000685	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—F2—hepatitis B	1.69e-05	0.000669	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TP53—hepatitis B	1.66e-05	0.000658	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR5—hepatitis B	1.65e-05	0.000654	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR5—hepatitis B	1.64e-05	0.000649	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—hepatitis B	1.62e-05	0.00064	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR5—hepatitis B	1.61e-05	0.000636	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—hepatitis B	1.6e-05	0.000635	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—hepatitis B	1.57e-05	0.000622	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL10—hepatitis B	1.57e-05	0.000621	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—F2—hepatitis B	1.53e-05	0.000608	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—hepatitis B	1.52e-05	0.000602	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.45e-05	0.000573	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—F2—hepatitis B	1.42e-05	0.000561	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—F2—hepatitis B	1.41e-05	0.000557	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.4e-05	0.000553	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT2—hepatitis B	1.39e-05	0.000549	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—F2—hepatitis B	1.38e-05	0.000545	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL10—hepatitis B	1.36e-05	0.000539	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—hepatitis B	1.31e-05	0.000519	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.3e-05	0.000516	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.29e-05	0.000509	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT2—hepatitis B	1.26e-05	0.0005	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR5—hepatitis B	1.22e-05	0.000482	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—hepatitis B	1.19e-05	0.000471	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT2—hepatitis B	1.16e-05	0.00046	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—hepatitis B	1.14e-05	0.000451	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT1—hepatitis B	1.09e-05	0.000432	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT1—hepatitis B	1.09e-05	0.000432	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR5—hepatitis B	1.06e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—F2—hepatitis B	1.04e-05	0.000413	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—hepatitis B	1.03e-05	0.000409	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT1—hepatitis B	1e-05	0.000397	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT1—hepatitis B	1e-05	0.000397	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.94e-06	0.000394	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—hepatitis B	9.55e-06	0.000378	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—hepatitis B	9.5e-06	0.000376	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—hepatitis B	9.48e-06	0.000375	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—hepatitis B	9.43e-06	0.000373	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—hepatitis B	9.28e-06	0.000367	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—hepatitis B	9.23e-06	0.000365	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CTNNB1—hepatitis B	9.22e-06	0.000365	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CTNNB1—hepatitis B	9.15e-06	0.000362	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—F2—hepatitis B	9.07e-06	0.000359	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CDKN1A—hepatitis B	9e-06	0.000356	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PTEN—hepatitis B	8.98e-06	0.000356	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CTNNB1—hepatitis B	8.96e-06	0.000355	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFKB1—hepatitis B	8.94e-06	0.000354	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CDKN1A—hepatitis B	8.94e-06	0.000354	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PTEN—hepatitis B	8.92e-06	0.000353	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFKB1—hepatitis B	8.87e-06	0.000351	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CDKN1A—hepatitis B	8.75e-06	0.000346	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTEN—hepatitis B	8.73e-06	0.000346	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFKB1—hepatitis B	8.69e-06	0.000344	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP2A6—hepatitis B	8.41e-06	0.000333	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT2—hepatitis B	7.6e-06	0.000301	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—hepatitis B	7.45e-06	0.000295	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—hepatitis B	7.39e-06	0.000293	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—hepatitis B	7.24e-06	0.000286	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—hepatitis B	7.03e-06	0.000278	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—hepatitis B	7e-06	0.000277	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	6.79e-06	0.000269	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	6.63e-06	0.000262	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTEN—hepatitis B	6.62e-06	0.000262	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFKB1—hepatitis B	6.58e-06	0.000261	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT1—hepatitis B	6.56e-06	0.00026	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT1—hepatitis B	6.56e-06	0.00026	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TP53—hepatitis B	6.13e-06	0.000243	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—hepatitis B	6.11e-06	0.000242	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TP53—hepatitis B	6.08e-06	0.000241	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—hepatitis B	6.08e-06	0.00024	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TP53—hepatitis B	5.96e-06	0.000236	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	5.89e-06	0.000233	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—hepatitis B	5.8e-06	0.00023	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	5.76e-06	0.000228	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTEN—hepatitis B	5.75e-06	0.000227	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFKB1—hepatitis B	5.72e-06	0.000226	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—hepatitis B	5.61e-06	0.000222	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—hepatitis B	5.57e-06	0.00022	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—hepatitis B	5.48e-06	0.000217	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—hepatitis B	5.45e-06	0.000216	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—hepatitis B	5.34e-06	0.000211	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—hepatitis B	4.76e-06	0.000189	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TP53—hepatitis B	4.52e-06	0.000179	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTEN—hepatitis B	4.43e-06	0.000175	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—hepatitis B	4.13e-06	0.000164	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTEN—hepatitis B	4.07e-06	0.000161	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TP53—hepatitis B	3.92e-06	0.000155	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—hepatitis B	3.59e-06	0.000142	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—hepatitis B	3.49e-06	0.000138	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTEN—hepatitis B	2.66e-06	0.000105	CbGpPWpGaD
